184 related articles for article (PubMed ID: 11881788)
41. 6-mercaptopurine dosage and pharmacokinetics influence the degree of bone marrow toxicity following high-dose methotrexate in children with acute lymphoblastic leukemia.
Schmiegelow K; Bretton-Meyer U
Leukemia; 2001 Jan; 15(1):74-9. PubMed ID: 11243403
[TBL] [Abstract][Full Text] [Related]
42. Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia.
Oosterom N; de Jonge R; Smith DEC; Pieters R; Tissing WJE; Fiocco M; van Zelst BD; van den Heuvel-Eibrink MM; Heil SG
PLoS One; 2019; 14(9):e0221591. PubMed ID: 31527879
[TBL] [Abstract][Full Text] [Related]
43. Intrathecal methotrexate-induced acute chorea.
Necioğlu Orken D; Yldrmak Y; Kenangil G; Kandraloğlu N; Forta H; Celik M
J Pediatr Hematol Oncol; 2009 Jan; 31(1):57-8. PubMed ID: 19125090
[TBL] [Abstract][Full Text] [Related]
44. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
45. Toxic epidermal necrolysis following combination of methotrexate and trimethoprim-sulfamethoxazole.
Yang CH; Yang LJ; Jaing TH; Chan HL
Int J Dermatol; 2000 Aug; 39(8):621-3. PubMed ID: 10971734
[TBL] [Abstract][Full Text] [Related]
46. Interaction between methotrexate and omeprazole in an adolescent with leukemia: a case report.
Bauters TG; Verlooy J; Robays H; Laureys G
Pharm World Sci; 2008 Aug; 30(4):316-8. PubMed ID: 18386155
[TBL] [Abstract][Full Text] [Related]
47. Acute tumor lysis syndrome following intrathecal methotrexate.
Benekli M; Güllü IH; Savaş MC; Kadayifçi A; Altundağ MK; Tekuzman G; Firat D
Leuk Lymphoma; 1996 Jul; 22(3-4):361-3. PubMed ID: 8819088
[TBL] [Abstract][Full Text] [Related]
48. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicity.
Wiczer T; Dotson E; Tuten A; Phillips G; Maddocks K
J Oncol Pharm Pract; 2016 Jun; 22(3):430-6. PubMed ID: 26152702
[TBL] [Abstract][Full Text] [Related]
50. Body Surface Area Dosing of High-Dose Methotrexate Should Be Reconsidered, Particularly in Overweight, Adult Patients.
Gallais F; Oberic L; Faguer S; Tavitian S; Lafont T; Marsili S; Brice A; Chatelut E; Puisset F
Ther Drug Monit; 2021 Jun; 43(3):408-415. PubMed ID: 32925658
[TBL] [Abstract][Full Text] [Related]
51. Risk factors for high-dose methotrexate-induced nephrotoxicity.
Kawaguchi S; Fujiwara SI; Murahashi R; Nakashima H; Matsuoka S; Ikeda T; Toda Y; Ito S; Ban T; Nagayama T; Umino K; Minakata D; Nakano H; Yamasaki R; Ashizawa M; Yamamoto C; Hatano K; Sato K; Oh I; Ohmine K; Kanda Y
Int J Hematol; 2021 Jul; 114(1):79-84. PubMed ID: 33743109
[TBL] [Abstract][Full Text] [Related]
52. High-dose methotrexate in acute lymphoblastic leukemia: where is the evidence for its continued use?
Mantadakis E; Cole PD; Kamen BA
Pharmacotherapy; 2005 May; 25(5):748-55. PubMed ID: 15899736
[TBL] [Abstract][Full Text] [Related]
53. The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia.
Gutierrez-Camino A; Oosterom N; den Hoed MAH; Lopez-Lopez E; Martin-Guerrero I; Pluijm SMF; Pieters R; de Jonge R; Tissing WJE; Heil SG; García-Orad A; van den Heuvel-Eibrink MM
Pharmacogenet Genomics; 2017 Aug; 27(8):303-306. PubMed ID: 28628559
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate.
Reddick WE; Glass JO; Helton KJ; Langston JW; Xiong X; Wu S; Pui CH
AJNR Am J Neuroradiol; 2005 May; 26(5):1263-9. PubMed ID: 15891195
[TBL] [Abstract][Full Text] [Related]
55. Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children.
Dufourg MN; Landman-Parker J; Auclerc MF; Schmitt C; Perel Y; Michel G; Levy P; Couillault G; Gandemer V; Tabone MD; Demeocq F; Vannier JP; Leblanc T; Leverger G; Baruchel A
Leukemia; 2007 Feb; 21(2):238-47. PubMed ID: 17170721
[TBL] [Abstract][Full Text] [Related]
56. Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia.
Rubnitz JE; Relling MV; Harrison PL; Sandlund JT; Ribeiro RC; Rivera GK; Thompson SJ; Evans WE; Pui CH
Leukemia; 1998 Aug; 12(8):1176-81. PubMed ID: 9697870
[TBL] [Abstract][Full Text] [Related]
57. Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited.
Sterba J; Dusek L; Demlova R; Valik D
Clin Chem; 2006 Apr; 52(4):692-700. PubMed ID: 16455868
[TBL] [Abstract][Full Text] [Related]
58. Cytarabine induced noncardiogenic pulmonary edema in a case of acute lymphoblastic leukemia.
Yegin ZA; Aki S; Sucak G; Yagci M
Int J Lab Hematol; 2007 Dec; 29(6):482-3. PubMed ID: 17988309
[No Abstract] [Full Text] [Related]
59. [SLCO1B1c. 521T>C gene polymorphisms are associated with high-dose methotrexate pharmacokinetics and clinical outcome of pediatric acute lymphoblastic leukemia].
Zhang H; He X; Li J; Wang Y; Wang C; Chen Y; Niu C; Gao P
Zhonghua Er Ke Za Zhi; 2014 Oct; 52(10):770-6. PubMed ID: 25537545
[TBL] [Abstract][Full Text] [Related]
60. Subacute leukencephalopathy after low-dose intrathecal methotrexate in an adolescent heterozygous for the MTHFR C677T polymorphism.
Strunk T; Gottschalk S; Goepel W; Bucsky P; Schultz C
Med Pediatr Oncol; 2003 Jan; 40(1):48-50. PubMed ID: 12426687
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]